<DOC>
	<DOCNO>NCT00562770</DOCNO>
	<brief_summary>To determine rate cytomegalovirus reactivation treatment alemtuzumab ( Campath ) reduce use valganciclovir prophylaxis .</brief_summary>
	<brief_title>Oral Valganciclovir Versus Valacyclovir</brief_title>
	<detailed_description>Researchers study effectiveness valganciclovir help prevent cytomegalovirus infection patient receive alemtuzumab . Since alemtuzumab eliminates T-cells , body 's usual defense virus , patient take alemtuzumab increase risk develop CMV . Before treatment , physical exam . You also around 3-4 tablespoon blood drawn routine test test see ever expose CMV . You randomly assign ( toss coin ) one two treatment group . Participants one group give treatment valganciclovir . Participants group give treatment valacyclovir . This drug protect herpes infection CMV . If assign group receive valganciclovir , take valganciclovir mouth day start first day alemtuzumab therapy . You continue take valganciclovir 2 month end alemtuzumab therapy . If assign group receive valacyclovir , take valacyclovir mouth day start first day alemtuzumab therapy . You continue take valacyclovir 2 month end alemtuzumab therapy . Every 2 week receive alemtuzumab ( usually 4-12 week ) repeat blood test look CMV . Your participation study last maximum 5 month . This investigational study . Both valganciclovir valacyclovir FDA approve commercially available . However , use valganciclovir study experimental . valganciclovir provide free charge study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Valacyclovir</mesh_term>
	<mesh_term>Acyclovir</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>Patients receive alemtuzumab Age &gt; 15 Signed inform consent form Active cytomegalovirus disease infection . Asymptomatic patient positive CMV pp65 antigenemia exclude . Patients creatinine clearance &lt; 10 ml/min calculate via CockcroftGault equation .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Chronic Lymphocytic Leukemia</keyword>
	<keyword>CLL</keyword>
	<keyword>Leukemia</keyword>
</DOC>